000 01518 a2200385 4500
005 20250517072004.0
264 0 _c20170817
008 201708s 0 0 eng d
022 _a1432-2277
024 7 _a10.1111/tri.12737
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRodríguez-Perálvarez, Manuel
245 0 0 _aBiopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal.
_h[electronic resource]
260 _bTransplant international : official journal of the European Society for Organ Transplantation
_cSep 2016
300 _a961-73 p.
_bdigital
500 _aPublication Type: Journal Article; Review; Systematic Review
650 0 4 _aBiomarkers
650 0 4 _aBiopsy
650 0 4 _aGraft Rejection
_ximmunology
650 0 4 _aGraft Survival
650 0 4 _aHumans
650 0 4 _aImmunosuppression Therapy
_xmethods
650 0 4 _aLiver
_xsurgery
650 0 4 _aLiver Failure
_xsurgery
650 0 4 _aLiver Transplantation
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aTreatment Outcome
700 1 _aRico-Juri, Jose M
700 1 _aTsochatzis, Emmanuel
700 1 _aBurra, Patrizia
700 1 _aDe la Mata, Manuel
700 1 _aLerut, Jan
773 0 _tTransplant international : official journal of the European Society for Organ Transplantation
_gvol. 29
_gno. 9
_gp. 961-73
856 4 0 _uhttps://doi.org/10.1111/tri.12737
_zAvailable from publisher's website
999 _c25584598
_d25584598